The Japanese Society of Hypertension (JSH) revised the Guidelines for the Management of
Hypertension 2014 (JSH 2014), and published the JSH 2019. In the development of the JSH …

Resistant hypertension (RHTN) is defined as uncontrolled blood pressure despite the use
of≥ 3 antihypertensive agents of different classes, including a diuretic, usually thiazide-like …

Importance Excess aldosterone production contributes to hypertension in both classical
hyperaldosteronism and obesity-associated hypertension. Therapies that reduce …

Background Optimal drug treatment for patients with resistant hypertension is undefined. We
aimed to test the hypotheses that resistant hypertension is most often caused by excessive …

Abstract Aims Mineralocorticoid receptor antagonists (MRAs) improve outcomes in patients
with heart failure and reduced left ventricular ejection fraction (HFrEF), but their use is limited …

The prevalence of resistant hypertension is unknown. Much previous knowledge comes
from referral populations or clinical trial participants. Using data from the National Health …

Hypertension, a global public health problem, is currently the leading factor in the global
burden of disease. It is the major modifiable risk factor for heart disease, stroke and kidney …

Resistant hypertension is a common clinical problem faced by both primary care clinicians
and specialists. While the exact prevalence of resistant hypertension is unknown, clinical …

Hypertension is the most common modifiable risk factor for cardiovascular disease and
death, and lowering blood pressure with antihypertensive drugs reduces target organ …

The elderly are the most rapidly growing population group in the world. Data collected over
a 30-year period have demonstrated the increasing prevalence of hypertension with age …